STAMPP HTN: Systemic Treatment and Management of Postpartum Hypertension
Course ID: 25OL00039
Launch Date: December 1, 2025
Expires On: November 30, 2026
Enduring Material
Free 1.0 ANCC
Registration Starts on December 1, 2025
-
Target Audience
This accredited continuing education activity is designed for nurses, interested health care providers, and community members.
Educational Objectives
- Identify the gaps in postpartum hypertension management that contribute to poor maternal health outcomes
- Describe the impact hospital-based programs have on compliance with postpartum hypertension management
- Explain the importance of blood pressure management in reducing disparities in healthcare
Method of Participation
Release Date: 12/1/2025
Expiration Date: 11/30/2026
The estimated time to complete this enduring material is 60 minutes.
In order to receive continuing education credits, you must complete these steps prior to the activity expiration date.
- View the entire presentation
- Complete the post-test with a score of 2 out of 3 or better
- Complete the online evaluation
- Save and print your certificate. Retain for future documentation.
Any questions regarding credit, please contact Valeta Creason-Wahl 402-559-7487 or vcreason@unmc.edu
Speaker Bio
Sarosh Rana, MD, MPH, FACOG
Professor of Obstetrics and Gynecology
Endowed Chris J. and Marie A. Olson Chair of Obstetrics and Gynecology
President of the Leland J. and Dorothy H. Olson Center for Women's Health
University of Nebraska Medical Center | Nebraska MedicineDr. Sarosh Rana completed her Medical Degree, Internship and Residency in Ob/Gyn at Jawaharlal Nehru Medical College in Aligarh, India. Dr. Rana completed an additional internship in General Surgery at Mayo Clinic in Rochester, Minnesota followed by Residencies in Ob/Gyn at the University of Minnesota and the University of Chicago. She completed her Fellowship in Maternal-Fetal Medicine at Brown University and Women & Infants Hospital of Rhode Island in Providence, Rhode Island. Lastly, she completed a Certificate and a Master of Public Health in Clinical Effectiveness at Harvard School of Public Health in Boston.
Dr. Rana is board-certified with both the American Board of Obstetrics and Gynecology and the Maternal-Fetal Medicine Subspecialty Board.
Accreditation

In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Olson Center for Women’s Health. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this activity for 1.0 ANCC contact hour. Nurses should only claim credit for the actual time spent participating in the activity.Disclosure Information
As a jointly accredited provider, the University of Nebraska Medical Center (UNMC) ensures accuracy, balance, objectivity, independence, and scientific rigor in its educational activities and is committed to protecting learners from promotion, marketing, and commercial bias. Faculty (authors, presenters, speakers) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.
All faculty, planners, and others in a position to control continuing education content participating in a UNMC accredited activity are required to disclose all financial relationships with ineligible companies. As defined by the Standards for Integrity and Independence in Accredited Continuing Education, ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The accredited provider is responsible for mitigating relevant financial relationships in accredited continuing education. Disclosure of these commitments and/or relationships is included in these activity materials so that participants may formulate their own judgments in interpreting its content and evaluating its recommendations.
This activity may include presentations in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications.
All materials are included with the permission of the faculty. The opinions expressed are those of the faculty and are not to be construed as those of UNMC.Disclosures
The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles:
Faculty
- Sarosh Rana, MD, MPH, FACOG
Consultant: Roche, Siemens, ThermoFisher
Planning Committee
- Valeta Creason-Wahl, CAPM, MMP
- Heidi Keeler, PhD, MSN/MBA, RN
- Lana Molczyk, MA
- Renee Paulin, DNP, MSN, RN, CWOCN
Financial Support
No commercial support was received for this activity.